PMC Links for Books (Select 4858410) - PMC

Select item 82600041.

Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study

Susan O’Brien, Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Pierluigi Porcu, Jeffrey Jones, Jan Burger, Nitin Jain, Kerstin Allen, Kerrie Faia, Mark Douglas, Howard M. Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Ian Flinn

Am J Hematol. Author manuscript; available in PMC 2021 Jul 6.

Published in final edited form as: Am J Hematol. 2018 Nov; 93(11): 1318–1326. Published online 2018 Oct 20. doi: 10.1002/ajh.25243

PMCID:: PMC8260004

Abstract Article PDF–630K

Select item 82392502.

The Evolving Use of PI3 Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia

Benjamin L. Lampson, Jennifer R. Brown

Hematol Oncol Clin North Am. Author manuscript; available in PMC 2022 Aug 1.

Published in final edited form as: Hematol Oncol Clin North Am. 2021 Aug; 35(4): 807–826. Published online 2021 May 27. doi: 10.1016/j.hoc.2021.03.009

PMCID:: PMC8239250

Abstract Article PDF–535K

Select item 78958673.

A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients

Matthew S. Davids, David C. Fisher, Svitlana Tyekucheva, Mikaela McDonough, John Hanna, Brandon Lee, Karen Francoeur, Josie Montegaard, Oreofe Odejide, Philippe Armand, Jon Arnason, Jennifer R. Brown

Leukemia. 2021; 35(4): 1064–1072. Published online 2020 Aug 20. doi: 10.1038/s41375-020-01010-6

PMCID:: PMC7895867

Abstract Article PDF–554K

Select item 62842164.

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Ian W. Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Árpád Illés, Gabriel Etienne, Julio Delgado, Bryone J. Kuss, Constantine S. Tam, Zoltán Gasztonyi, Fritz Offner, Scott Lunin, Francesco Bosch, Matthew S. Davids, Nicole Lamanna, Ulrich Jaeger, Paolo Ghia, Florence Cymbalista, Craig A. Portell, Alan P. Skarbnik, Amanda F. Cashen, David T. Weaver, Virginia M. Kelly, Barry Turnbull, Stephan Stilgenbauer

Blood. 2018 Dec 6; 132(23): 2446–2455. Prepublished online 2018 Oct 4. doi: 10.1182/blood-2018-05-850461

PMCID:: PMC6284216

Abstract Article

Select item 62207895.

Duvelisib, an oral dual PI3K‐δ, γ inhibitor, shows clinical activity in indolent non‐Hodgkin lymphoma in a phase 1 study

Ian W. Flinn, Manish Patel, Yasuhiro Oki, Steven Horwitz, Francine F. Foss, Kerstin Allen, Mark Douglas, Howard Stern, Jennifer Sweeney, Jahnavi Kharidia, Patrick Kelly, Virginia M. Kelly, Brad Kahl

Am J Hematol. 2018 Nov; 93(11): 1311–1317. Published online 2018 Aug 31. doi: 10.1002/ajh.25228

PMCID:: PMC6220789

Abstract Article PDF–1.0M

Select item 49462006.

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

Benjamin L. Lampson, Siddha N. Kasar, Tiago R. Matos, Elizabeth A. Morgan, Laura Rassenti, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Caron A. Jacobson, Philippe Armand, Jeremy S. Abramson, Jon E. Arnason, Thomas J. Kipps, Joshua Fein, Stacey Fernandes, John Hanna, Jerome Ritz, Haesook T. Kim, Jennifer R. Brown

Blood. 2016 Jul 14; 128(2): 195–203. Prepublished online 2016 May 31. doi: 10.1182/blood-2016-03-707133

PMCID:: PMC4946200

Abstract Article

Select item 41613657.

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

Richard R. Furman, Jeff P. Sharman, Steven E. Coutre, Bruce D. Cheson, John M. Pagel, Peter Hillmen, Jacqueline C. Barrientos, Andrew D. Zelenetz, Thomas J. Kipps, Ian Flinn, Paolo Ghia, Herbert Eradat, Thomas Ervin, Nicole Lamanna, Bertrand Coiffier, Andrew R. Pettitt, Shuo Ma, Stephan Stilgenbauer, Paula Cramer, Maria Aiello, Dave M. Johnson, Langdon L. Miller, Daniel Li, Thomas M. Jahn, Roger D. Dansey, Michael Hallek, Susan M. O’Brien

N Engl J Med. Author manuscript; available in PMC 2014 Sep 11.

Published in final edited form as: N Engl J Med. 2014 Mar 13; 370(11): 997–1007. Published online 2014 Jan 22. doi: 10.1056/NEJMoa1315226

PMCID:: PMC4161365

Abstract Article PDF–461K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 7

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity